BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5193899)

  • 21. Neurological symptoms in a cat following vaccination with high egg passage Flury rabies vaccine of chicken embryo origin.
    Barnard BJ; Geyer HJ; De Koker WC
    Onderstepoort J Vet Res; 1977 Sep; 44(3):195-6. PubMed ID: 614535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Asymptomatic canine rabies and public health.
    Sherikar AA
    Indian J Public Health; 1991; 35(3):80-2. PubMed ID: 1823336
    [No Abstract]   [Full Text] [Related]  

  • 23. Warning on rabies vaccines.
    Rosen DK
    Wis Med J; 1987 Dec; 86(12):6. PubMed ID: 3424861
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The complement-fixation test in rabies. I. Antibody titer of vaccinated dogs (author's transl)].
    Nilsson TT; Pinto AA; Nilsson MR
    Arq Inst Biol (Sao Paulo); 1975; 42():197-202. PubMed ID: 1236050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rabies immunity of dogs vaccinated with the Flury HEP vaccine prepared on chick embryo].
    Ribeiro M
    Arch Inst Pasteur Alger; 1970; 48():139-49. PubMed ID: 5535879
    [No Abstract]   [Full Text] [Related]  

  • 27. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
    Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suckling-mouse-brain rabies vaccine (SMBV): duration of immunity in dogs.
    Fields M; Ament RD; Lamb D; Blades J
    Vet Med Small Anim Clin; 1976 Jan; 71(1):37-40. PubMed ID: 1044175
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immune rabies status of 200 vaccinated dogs from the canton of Zurich].
    Engels M; Flückiger M; Knüsli K; Wyler R
    Schweiz Arch Tierheilkd; 1982 Mar; 124(3):149-56. PubMed ID: 7201161
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonfatal canine rabies.
    Arko RJ; Schneider LG; Baer GM
    Am J Vet Res; 1973 Jul; 34(7):937-8. PubMed ID: 4720680
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of monoclonal antibodies to confirm vaccine-induced rabies in ten dogs, two cats, and one fox.
    Whetstone CA; Bunn TO; Emmons RW; Wiktor TJ
    J Am Vet Med Assoc; 1984 Aug; 185(3):285-8. PubMed ID: 6540768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of abortive canine rabies in Chiang Mai, Thailand.
    Yasmuth C; Nelson KE; Laima T; Supawadee J; Thaiyanant P
    J Med Assoc Thai; 1983 Mar; 66(3):169-75. PubMed ID: 6854177
    [No Abstract]   [Full Text] [Related]  

  • 33. Rabies induced in a cat by high-egg-passage Flury strain vaccine.
    Bellinger DA; Chang J; Bunn TO; Pick JR; Murphy M; Rahija R
    J Am Vet Med Assoc; 1983 Nov; 183(9):997-8, 965. PubMed ID: 12002593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis of neurovirulence of flury rabies virus vaccine strains: importance of the polymerase and the glycoprotein R333Q mutation.
    Tao L; Ge J; Wang X; Zhai H; Hua T; Zhao B; Kong D; Yang C; Chen H; Bu Z
    J Virol; 2010 Sep; 84(17):8926-36. PubMed ID: 20538851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rabies peripheral challenge test: more accurate determination of vaccine potency.
    Wunderli PS; Dreesen DW; Miller TJ; Baer GM
    Vaccine; 2006 Nov; 24(49-50):7115-23. PubMed ID: 16919854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.
    Bahloul C; Taieb D; Diouani MF; Ahmed SB; Chtourou Y; B'chir BI; Kharmachi H; Dellagi K
    Vaccine; 2006 Feb; 24(8):1063-72. PubMed ID: 16213633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabies control in Mexico.
    Lucas CH; Pino FV; Baer G; Morales PK; Cedillo VG; Blanco MA; Avila MH
    Dev Biol (Basel); 2008; 131():167-75. PubMed ID: 18634477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
    Zhang S; Liu Y; Zhang F; Hu R
    Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The delivery of oral rabies vaccines to dogs: an African perspective.
    Perry BD; Wandeler AI
    Onderstepoort J Vet Res; 1993 Dec; 60(4):451-7. PubMed ID: 7777335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of a live canine adenovirus-vectored rabies virus vaccine in swine.
    Liu Y; Zhang S; Ma G; Zhang F; Hu R
    Vaccine; 2008 Oct; 26(42):5368-72. PubMed ID: 18721839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.